Ramrada LekwuttikarnShellie JosephsJoyce M. TengStanford University School of MedicineFaculty of Medicine, Ramathibodi Hospital, Mahidol University2020-01-272020-01-272019-01-01Pediatrics. Vol.144, No.4 (2019)10984275003140052-s2.0-85072848773https://repository.li.mahidol.ac.th/handle/123456789/52307Copyright © 2019 by the American Academy of Pediatrics Hepatic hemangioma (HH) is a common asymptomatic, self-limiting benign vascular tumor of the liver in neonates. Although complicated HHs are rare, they have significant risks of morbidity and mortality, especially during the perinatal period. Because of the high risks of complications from surgical interventions, there is an unmet need for effective medical therapy. We report 2 neonates with life-threatening HH who were evaluated for a liver transplant before being treated successfully with combined medical therapy, which included sirolimus, corticosteroids, and propranolol.Mahidol UniversityMedicineArticleSCOPUS10.1542/peds.2019-1339